Attitudes of Patients about Personalized Medicine | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Understanding the Role of Personalized Medicine

recurrence risk for breast cancer »

Attitudes of Patients about Personalized Medicine

March 2, 2013 by larryhbern

Attitudes of Patients about Personalized Medicine

Curator: Larry H Bernstein, MD, FCAP

Attitudes of Patients With Cancer About Personalized Medicine

SW Gray, K Hicks-Courant, et al.

jop.ascopubs.org/content/8/6/329.full.pdf

http://ovariancancerandus.blogspot.com/…/jop-attitudes-of-patients-With-Cancer-About-Personalized-Medicine-and-Somatic-Genetic-Testing/

Personalized Medicine

Personalized Medicine (Photo credit: Wikipedia)

Related articles

Personalized medicine gearing up to tackle cancer (pharmaceuticalintelligence.com)
http://pharmaceuticalintelligence.com/wp-admin/Understanding_the_Role_of_Personalized_Medicine
Nanotechnology, personalized medicine and DNA sequencing (pharmaceuticalintelligence.com)
Institute for Personalized Medicine established by UPMC (triblive.com)
Personalized medicine: the future of medicine! (gtms1314.wordpress.com)
http://pharmaceuticalintelligence.com/2013/01/13/paradigm-shift-in-human-genomics-predictive-biomarkers-and-personalized-medicine-part-1/
http://pharmaceuticalintelligence.com/2013/02/27/genomics-ethics-dna-fragments-are-products-of-nature-or-patentable-genes/

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Economics and Outcomes Research, Health Law & Patient Safety, International Global Work in Pharmaceutical, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Population Health Management, Genetics & Pharmaceutical, Technology Transfer: Biotech and Pharmaceutical | Tagged Biology, Cancer - General, Conditions and Diseases, health, Larry H. Bernstein, medicine, Ohio State University Medical Center, ovarian cancer, Personalized medicine | 5 Comments

5 Responses

on March 3, 2013 at 9:21 PM | Reply The Promise of Personalized Medicine | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com) […]

Loading...
on March 27, 2013 at 5:45 PM | Reply Ethical Concerns in Personalized Medicine: BRCA1/2 Testing in Minors and Communication of Breast Cancer Risk | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine […]

Loading...
on March 27, 2013 at 7:00 PM | Reply Genomic Liberty of Ownership, Genome Medicine and Patenting the Human Genome | Pharmaceutical Intelligence

[…] 20.3 Attitudes of Patients about Personalized Medicine […]

Loading...
on April 3, 2013 at 9:21 AM | Reply Paralysis by Sequestration and the Medical Revolution | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com) […]

Loading...
on July 24, 2014 at 12:33 PM | Reply Series B: Frontiers in Genomics Research | Scientific Curation Services

[…] 20.3 Attitudes of Patients about Personalized Medicine […]

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,673 other subscribers

Email Address
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: